Malaria: all 1,315 studies
Page 1 of 14. Open to participants first (86), then studies with results posted, then the rest; newest registration first within each.
- Humanitarian Evaluation of Spatial Emanators for Malaria ControlNot yet recruitingNCT07886281Phase 4
- Positron Emission Tomography and Organ-Specific Changes in Participants Co-Enrolled in NIH Studies of Plasmodium Vivax Controlled Human Malaria InfectionNot yet recruitingNCT07859800Not applicable
- Safety and Immunogenicity of the Recombinant Malaria Vaccines in Healthy Adults Aged 18-50 YearsNot yet recruitingNCT07831226Phase 1
- OPTIMAL LEAP: Optimizing Dihydroartemisinin-Piperaquine IPTsc Intervals to Advance Learning, Executive Function, Attendance, and Antimalarial Resistance Surveillance in Kenyan SchoolchildrenNot yet recruitingNCT07798583Phase 3
- Insecticide-Treated Baby Wraps for the Prevention of MalariaNot yet recruitingNCT07773350Not applicable
- Community-Based Cohort Study of Hidden Malaria Infections, Diagnostic Gaps, & Mosquito Vector Dynamics in Odisha, IndiaRecruitingNCT07770048
- Safety, Tolerability, Pharmacokinetics, and Mosquitocidal Activity of Lotilaner in Healthy Participants in Mali.RecruitingNCT07758985Phase 1
- Assessing Vaccine Effectiveness of R21/Matrix-M Across Malaria Transmission Settings (AVERT)RecruitingNCT07749911
- Study to Assess Safety and Clinical Responses With Coartem® Baby Dispersible Tablets in Paediatric Patients Weighing 2 to <5 kg With Uncomplicated MalariaNot yet recruitingNCT07713602Phase 4
- Integrating the Guardian Spatial Emanator Within AVENIR IINot yet recruitingNCT07712263Not applicable
- PfSPZ-LARC2 Vaccine in Women of Child-bearing Potential (WOCBP) in MaliRecruitingNCT07675785Phase 2
- First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in Healthy AdultsRecruitingNCT07646353Phase 1
- Safety and PK of MMV371 LAI in Healthy Adults and Adolescents in RwandaNot yet recruitingNCT07548021Phase 1
- A Phase 2A Study of a Novel Antimalarial Pyrrolidinamide in Adult Patients With Uncomplicated P. Falciparum MalariaNot yet recruitingNCT07545681Phase 2
- Xpert® Tropical Fever Test on GeneXpert® Edge X SystemEnrolling by invitationNCT07520279
- A Clinical Study of Piperaquine, Pyronaridine, and Artesunate Administered in Combination in Healthy AdultsNot yet recruitingNCT07470424Phase 1
- An Ultra-short Course of Primaquine for the Radical Cure of Vivax MalariaNot yet recruitingNCT07468526Phase 3
- Non-invasive Malaria Diagnostic Data Collection in EthiopiaRecruitingNCT07456969
- This is a Clinical Study to Assess Whether the Combination of SJ733 and Tafenoquine Will be a Safe and Rapidly Acting Anti-malarial for the Radical Cure of P. Vivax MalariaNot yet recruitingNCT07430592Phase 2
- Effectiveness of Malaria Vaccines in Reducing the Risk of Invasive Non-typhoidal Salmonella DiseaseRecruitingNCT07416461
- Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of GhanaRecruitingNCT07389057Not applicable
- Long-acting Spatial Emanators / Repellents (LASER)Not yet recruitingNCT07387341Not applicable
- Field Trial of PfSPZ-LARC2 Vaccine in Burkinabe AdultsRecruitingNCT07385287Phase 2
- Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveRecruitingNCT07358910
- Clinical Aspects, Management and Surveillance of Febrile Illnesses in DRCRecruitingNCT07345286
- Introduction of Polymerase Chain Reaction (PCR) in Microbiology and ParasitologyRecruitingNCT07269314
- Testing a Biometric Identification System to Improve Malaria Vaccine CompletionRecruitingNCT07261280Not applicable
- Clinical Study to Assess Minimum Mosquito Bites for P. Vivax Infection in Thai AdultsRecruitingNCT07257965Not applicable
- Intermittent Preventive Treatment of Malaria in School-age Children to Decrease Community TransmissionNot yet recruitingNCT07246525Phase 4
- R21/MM Dosing, Presentations, and PreservativesNot yet recruitingNCT07194668Phase 4
- Clinical Trial to Evaluate the Safety and Immunogenicity of the Vivaxin Vaccine for Malaria Caused by Plasmodium Vivax."Not yet recruitingNCT07172724Phase 1
- Comparison of Two Strategies for Administering the R21-Matrix M Vaccine in a Context of Seasonal Malaria Transmission in ChadRecruitingNCT07038837Phase 4
- A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 MonthsRecruitingNCT07036159Phase 2
- Focal Mass Drug Administration for the Prevention of Malaria in PregnancyRecruitingNCT07021430Early Phase 1
- Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of LAI MMV055 Alone and in Combination With MMV371 in Healthy ParticipantsRecruitingNCT07011511Phase 1
- An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria VaccineRecruitingNCT07009847
- OPTImizing Malaria And HIV Treatment in a Shifting Landscape in AfricaRecruitingNCT06967519Phase 4
- Safety of Antimalarials in the FIRst trimEsterRecruitingNCT06962319Phase 3
- Experimental Malaria Infection of Healthy Malaria-Naive Adults by Mosquito Bite With the Genetically Modified Plasmodium Falciparum NF54/iGP3 GAPNot yet recruitingNCT06881732Phase 1
- Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Naïve AdultsRecruitingNCT06862453Phase 1
- Integrating Malaria Vaccine With Seasonal Malaria Chemoprevention in West AfricaRecruitingNCT06860178Phase 4
- Surveillance of AMR in DRCRecruitingNCT06821282
- The Effects of Iron Treatment on Malaria and Measles Vaccine Response in Kenyan Infants With Iron DeficiencyNot yet recruitingNCT06816524Not applicable
- Severe Malaria in Remote Areas- Closing the Evidence GapEnrolling by invitationNCT06806956
- Host Immunity, Plasmodium and Pathogens Co-InfectionsNot yet recruitingNCT06769815Not applicable
- Enhancing Pediatric Acute Care Through Adaptive E-Learning and In-Person Skills Practice in TanzaniaNot yet recruitingNCT06635733Not applicable
- PDMC Implementation Trial in KenyaRecruitingNCT06624631Phase 4
- Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding AssaysRecruitingNCT06607003Phase 1
- Post-discharge Malaria Chemoprevention Implementation Trial in BeninRecruitingNCT06601712Phase 4
- Diagnostic Access to Self-Care and Health Services in Low and Middle Income Countries (DASH) - Phase IINot yet recruitingNCT06588790Not applicable
- Seasonal R21 Mass Vaccination for Malaria EliminationRecruitingNCT06578572Phase 3
- Evaluation of Artesunate in Infants Being Treated for Severe MalariaRecruitingNCT06555809
- Pregnancy Registry in MaliRecruitingNCT06468319
- The Impact RTS,S/AS01 Vaccine in School Aged Children RTS,S/AS01 Malaria Vaccine in School Aged ChildrenNot yet recruitingNCT06424002Phase 4
- Physiology and Pathologies Linked to Human Splenic Function : Direct and Ex-vivo Perfusion ExplorationsRecruitingNCT06418256
- Seasonal Malaria Chemoprevention Rapid Assessment Study MozambiqueNot yet recruitingNCT06337253Phase 4
- Durability of Protection After Single Immunisation With GA2 Sporozoites (CoGA-Rechallenge)Not yet recruitingNCT06293339Phase 1
- Effectiveness and Cost-effectiveness of Integrated Model for Malaria and Helminth ControlNot yet recruitingNCT06182176Not applicable
- In-vivo Transmission Model in Semi-immune AdultsNot yet recruitingNCT06172686Phase 1
- Malaria Burden in Pregnant Women and the Incidence of Pregnancy in a Cohort of NulligravidaRecruitingNCT06162078
- Chemoprevention Efficacy Study NigeriaRecruitingNCT05979896Phase 4
- Innovative Intermittent Preventive Treatment Approaches to Reduce Malaria Burden in School-age Children in Burkina FasoRecruitingNCT05946642Phase 3
- L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)RecruitingNCT05934318Not applicable
- Plasmodium Immunotherapy for Advanced Ovarian CancerNot yet recruitingNCT05924776Phase 2/3
- A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum CarriersRecruitingNCT05911828Phase 1
- Addressing Asymptomatic Plasmodium Reservoirs to Accelerate Malaria Elimination and Eradication in Rwanda.Not yet recruitingNCT05801198Phase 2
- ACT vs CQ With Tafenoquine for P. Vivax Mono-infectionRecruitingNCT05788094Phase 4
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum MalariaRecruitingNCT05750628Phase 2
- Platelet-Directed Whole Blood Transfusion Strategy for MalariaRecruitingNCT05711485Not applicable
- FocaL Mass Drug Administration for Vivax Malaria EliminationRecruitingNCT05690841Phase 3
- DON in Pediatric Cerebral MalariaRecruitingNCT05478720Phase 1/2
- Comparing Safety and Protective Efficacy of Vaccine Candidate PfSPZ-CVac and MVA ME-TRAP/ ChAd63 ME-TRAP in AdultsNot yet recruitingNCT05441410Phase 1/2
- Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their InfantsRecruitingNCT05285735
- Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria VaccineRecruitingNCT05041556
- Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and MalariaNot yet recruitingNCT04672577
- Effect of Paracetamol on Kidney Function in Severe MalariaRecruitingNCT04251351Phase 3
- Plasmodium Immunotherapy for Advanced Malignant Solid TumorsRecruitingNCT04165590Phase 1/2
- Malaria Birth Cohort (MBC) in Agogo, GhanaRecruitingNCT04050566
- Collection of Human Biospecimens for Basic and Clinical Research Into Globin VariantsRecruitingNCT03937817
- Plasmodium Immunotherapy for Breast and Liver CancersRecruitingNCT03474822Phase 1/2
- Plasmodium Immunotherapy for Advanced CancersRecruitingNCT03375983Phase 1/2
- Plasmodium Immunotherapy for Lung CancerRecruitingNCT02786589Phase 1/2
- Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria ChallengeRecruitingNCT02639299
- Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine CandidatesRecruitingNCT02471378
- Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, MaliRecruitingNCT01168271
- Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic InfectionRecruitingNCT00001645
- L9LS MAb in Malian InfantsCompletedNCT06461026Phase 1Results posted
- A Clinical Trial to Evaluate the Safety, Efficacy and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against MalariaCompletedNCT06069544Phase 1/2Results posted
- Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. FalciparumCompletedNCT05979207Phase 1Results posted
- Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2)CompletedNCT05974267Phase 2Results posted
- Piperaquine Granule Formulation Relative Bioavailability and Food Effect Study in Healthy Volunteers.CompletedNCT05930782Phase 1Results posted
- Safety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy AdultsCompletedNCT05891236Phase 1Results posted
- L9LS MAb in Malian AdultsCompletedNCT05816330Phase 2Results posted
- Pharmacokinetic Study of IV Artesunate to Treat Children With Severe MalariaCompletedNCT05750459Phase 4Results posted
- A Phase 1 Trial of PfSPZ Vaccine in Healthy Adults to Determine Safety, Tolerability and Efficacy Against Heterologous CHMITerminatedNCT05604521Phase 1Results posted
- Safety and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against MalariaCompletedNCT05581641Phase 1Results posted
- First-in-Human Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV367CompletedNCT05507970Phase 1Results posted
- A Study of the Plasmodium Falciparum Malaria Vaccine Candidate Pfs48/45 in Matrix-M Adjuvant in the UKTerminatedNCT05400746Early Phase 1Results posted
- Anti-malaria MAb in Kenyan ChildrenCompletedNCT05400655Phase 2Results posted
- Anti-malaria MAb in Malian ChildrenCompletedNCT05304611Phase 2Results posted